Pharmacy Times

FEBRUARY 19, 2025

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

139

139

Drug Topics

FEBRUARY 18, 2025

Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.

Dosage 593

Dosage 593

STAT

FEBRUARY 20, 2025

In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight dropped so much that researchers reduced her dose of the treatment, called retatrutide.

145

145

PhRMA

FEBRUARY 19, 2025

Earlier this year, the American Cancer Society (ACS) released its annual report on cancer facts and trends – Cancer Statistics 2025. Notably, this new report found that the cancer mortality rate declined in the U.S. by an astounding 34% since peaking in 1991, averting 4.5 million deaths.

205

205

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

FEBRUARY 20, 2025

Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and interdisciplinary collaboration. They provide targeted medication therapy, monitor drug interactions, offer medication counseling, manage chronic conditions, support reproductive health, and help patients navigate complex treatment regimens with expertise and compassionate care.

102

102

Drug Topics

FEBRUARY 19, 2025

The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.

FDA 463

FDA 463

The Checkup by Singlecare

FEBRUARY 18, 2025

Jardiance (empagliflozin) is a brand-name prescription drug that has been FDA approved as a supplement to diet and exercise to improve blood sugar levels in people with Type 2 diabetes. It is also FDA-approved to treat chronic kidney disease (CKD) in those at risk of progression and reduce the risk of cardiovascular death in adults with either heart failure or Type 2 diabetes and cardiovascular disease.

Dosage 80

Dosage FDA Hospitals 80

PharmaVoice

FEBRUARY 19, 2025

The Young Institute Pharmaceutical Manufacturing Consortium will research and develop new production technologies.

174

174

Drug Topics

FEBRUARY 20, 2025

Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.

453

453

STAT

FEBRUARY 20, 2025

Change has come to the Department of Health and Human Services. With the confirmation of Robert F. Kennedy Jr. as secretary, major shifts in organizational structure, staffing , and policy priorities across the department are already underway. But not all HHS agencies are created equal, and some deserve to be modified with a scalpel rather than a sledgehammer.

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

FEBRUARY 20, 2025

PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world.

Vaccines 142

Vaccines 142

PharmaVoice

FEBRUARY 21, 2025

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf, of the layoffs.

FDA 173

FDA 173

Drug Topics

FEBRUARY 20, 2025

From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.

446

446

STAT

FEBRUARY 20, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I was a bit worried last week’s angst-y rant on the bleak state of biotech investing would turn folks off. In fact, it was my most popular newsletter ever, with the version posted to STAT’s website delivering a ton of new subscribers.

114

114

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

FEBRUARY 17, 2025

The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

PharmaVoice

FEBRUARY 18, 2025

Scribe Therapeutics hopes to prevent cardiometabolic diseases by targeting underlying causes with CRISPR technology.

147

147

Drug Topics

FEBRUARY 20, 2025

Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.

Community Pharmacies 380

Community Pharmacies 380

STAT

FEBRUARY 17, 2025

A few decades ago, hotels were supreme. They had strong relationships with their customers, who were deeply loyal to particular hotels they trusted. But that has changed with the rise of online travel agencies (OTAs) like Booking.com and Expedia. Since the late 1990s, these OTAs have dramatically reshaped the travel industry. By offering travelers the ability to compare prices and book accommodations from thousands of options, OTAs brought convenience, transparency, and lower costs.

Hospitals 95

Hospitals 95

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

FEBRUARY 20, 2025

Panelists discuss how menopause represents a complex physiological transition characterized by hormonal fluctuations, reproductive system changes, and multifaceted symptoms affecting physical, psychological, and metabolic health. Comprehensive patient education, personalized management strategies, and holistic support are crucial for navigating this transformative life stage.

141

141

Pharmafile

FEBRUARY 17, 2025

Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment of acute bacterial skin and skin structure infections (ABSSSIs), including diabetic foot infections (DFI). R327, a broad-spectrum antibiotic topical gel, was tested in a phase 2 open-label trial that evaluated its safety, tolerability, efficacy and […] The post Recce Pharmaceuticals reports positive phase 2 data for skin infection drug appeared first on Pharma

Labelling 59

Labelling 59

Drug Topics

FEBRUARY 21, 2025

Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.

355

355

STAT

FEBRUARY 18, 2025

Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome, a severe form of epilepsy, outside the U.S., the companies said Tuesday.  For Biogen, acquiring international commercial rights to the Stoke drug bolsters its rare disease and neurology pipeline, and provides another product that could help it return to growth in the latter part of the decade.

85

85

Pharmacy Times

FEBRUARY 20, 2025

Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.

136

136

Fierce Healthcare

FEBRUARY 19, 2025

NASHVILLE, TennesseeThe Cleveland Clinic conducted a head-to-head comparison of five AI scribe products from major vendors. It found underlying differences in the technology and variation in how quickly the vendors responded to issues, executives said.

136

136

Drug Topics

FEBRUARY 20, 2025

A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.

351

351

STAT

FEBRUARY 18, 2025

California officials were dealt a setback by a federal judge who ruled that a controversial law banning so-called pay-to-delay deals between pharmaceutical companies is, in part, unconstitutional and so cannot be enforced against agreements that had no link to the state. In his ruling , U.S. District Court Judge Troy Nunley determined that the state law, which was enacted in 2019, violated the Dormant Commerce Clause of the U.S.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies 76

Pharma Marketing Network

FEBRUARY 17, 2025

Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.

Hospitals 52

Hospitals FDA 52

Fierce Healthcare

FEBRUARY 21, 2025

The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.

134

134

Drug Topics

FEBRUARY 19, 2025

Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.

315

315

STAT

FEBRUARY 17, 2025

Dear Readers, I’m thrilled to share the news today that four STAT reporters have won the George W. Polk Award , one of the most prestigious honors in American journalism, for their series that highlights how UnitedHealth Group wields its unrivaled physician empire to boost its profits and expand its influence.

145

145

The Checkup by Singlecare

FEBRUARY 17, 2025

Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. The side effects of compounded semaglutide can range from mild digestive issues to more severe complications, like low blood sugar (hypoglycemia) or gallbladder problems.

Compounding 52

Compounding Compounding Pharmacies FDA Dosage 52

Fierce Healthcare

FEBRUARY 21, 2025

Congress and state leaders must resist short-term cost-cutting measures that cause long-term harm, create cycles of poverty and dismantle the middle class.

133

133

Drug Topics

FEBRUARY 21, 2025

Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.

307

307